Respiratory syncytial virus

Question 1

How do you treat severe bronchiolitis caused by respiratory syncytial virus (RSV) in infants?

Answer 1

Ribavarin

Question 2

What medication can be used to prevent serious lower respiratory-tract disease caused by respiratory syncytial virus in children at high risk?

Answer 2

Palvizumab

Question 3

TRUE OR FALSE:

Palivizumab is recommended for children under 18 months of age with chronic lung disease and who were born pre-term

Answer 3

False.

Palivizumab is recommended for children under 9 months of age with chronic lung disease and who were born pre-term

Question 4

TRUE OR FALSE:

Palivizumab is recommended in children under 6 months of age with haemodynamically significant, acynotic congenital heart disease who were born pre-term

Answer 4

True

Question 5

TRUE OR FALSE:

Palivizumab is recommended in children under 2 years of age with severe combined immunodeficiency syndrome

Answer 5

True

Question 6

TRUE OR FALSE:

Palivizumab is recommended for children under 4 years of age who require long-term venitilation.

Answer 6

False.

Palivizumab is recommended for children under 1 year of age who require long-term ventilation

Question 7

TRUE OR FALSE:

Palivizumab is recommended for children of 4-5 years of age who require long-term ventilation and have an additional co-morbidity (including cardiac disease or pulmonary hypertension)

Answer 7

False.

Palivizumab is recommended for children of 1-2 years of age who require long-term ventilation and have an additional co-morbidity (including cardiac disease or pulmonary hypertension)